NewzInnovative medications for the control of obesity and diabetes were incorporated into the Basic Medication Formulary of the Dominican Republic more than a year ago. However, their official inclusion has not yet translated into effective coverage for patients through health risk administrators (ARS).
The delay leaves individuals requiring these treatments without financial assistance or accessible distribution through their health insurance plans, highlighting a persistent gap between regulatory approvals and practical implementation in the country's healthcare system.
In-depth summary · AI, neutral